117 results on '"Gougeon, M.L."'
Search Results
2. Le lichen plan érosif est caractérisé par l’expansion locale et périphérique de lymphocytes T CD8+ spécifiques de HPV 16E711–20
- Author
-
Viguier, M., primary, Bachelez, H., additional, Poirier, B., additional, Kagan, J., additional, Battistella, M., additional, Aubin, F., additional, Touzé, A., additional, Carmagnat, M., additional, Francès, C., additional, Gougeon, M.L., additional, and Fazilleau, N., additional
- Published
- 2015
- Full Text
- View/download PDF
3. From Classical to Alternative Pathways of 2-Arachidonoylglycerol Synthesis: AlterAGs at the Crossroad of Endocannabinoid and Lysophospholipid Signaling.
- Author
-
Briand-Mésange, Fabienne, Gennero, Isabelle, Salles, Juliette, Trudel, Stéphanie, Dahan, Lionel, Ausseil, Jérôme, Payrastre, Bernard, Salles, Jean-Pierre, and Chap, Hugues
- Subjects
PHOSPHODIESTERASES ,HYDROLASES ,BONE growth ,LYSOPHOSPHOLIPIDS ,AUTOTAXIN ,CANNABINOID receptors - Abstract
2-arachidonoylglycerol (2-AG) is the most abundant endocannabinoid (EC), acting as a full agonist at both CB1 and CB2 cannabinoid receptors. It is synthesized on demand in postsynaptic membranes through the sequential action of phosphoinositide-specific phospholipase Cβ1 (PLCβ1) and diacylglycerol lipase α (DAGLα), contributing to retrograde signaling upon interaction with presynaptic CB1. However, 2-AG production might also involve various combinations of PLC and DAGL isoforms, as well as additional intracellular pathways implying other enzymes and substrates. Three other alternative pathways of 2-AG synthesis rest on the extracellular cleavage of 2-arachidonoyl-lysophospholipids by three different hydrolases: glycerophosphodiesterase 3 (GDE3), lipid phosphate phosphatases (LPPs), and two members of ecto-nucleotide pyrophosphatase/phosphodiesterases (ENPP6–7). We propose the names of AlterAG-1, -2, and -3 for three pathways sharing an ectocellular localization, allowing them to convert extracellular lysophospholipid mediators into 2-AG, thus inducing typical signaling switches between various G-protein-coupled receptors (GPCRs). This implies the critical importance of the regioisomerism of both lysophospholipid (LPLs) and 2-AG, which is the object of deep analysis within this review. The precise functional roles of AlterAGs are still poorly understood and will require gene invalidation approaches, knowing that both 2-AG and its related lysophospholipids are involved in numerous aspects of physiology and pathology, including cancer, inflammation, immune defenses, obesity, bone development, neurodegeneration, or psychiatric disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Focused Ultrasound-Mediated Disruption of the Blood–Brain Barrier for AAV9 Delivery in a Mouse Model of Huntington's Disease.
- Author
-
Owusu-Yaw, Bernie S., Zhang, Yongzhi, Garrett, Lilyan, Yao, Alvin, Shing, Kai, Batista, Ana Rita, Sena-Esteves, Miguel, Upadhyay, Jaymin, Kegel-Gleason, Kimberly, and Todd, Nick
- Subjects
HUNTINGTON disease ,BLOOD-brain barrier ,MICROBUBBLE diagnosis ,LABORATORY mice ,ANIMAL disease models ,TRINUCLEOTIDE repeats ,CENTRAL nervous system - Abstract
Huntington's disease (HD) is a monogenic neurodegenerative disorder caused by a cytosine–adenine–guanine (CAG) trinucleotide repeat expansion in the HTT gene. There are no cures for HD, but the genetic basis of this disorder makes gene therapy a viable approach. Adeno-associated virus (AAV)-miRNA-based therapies have been demonstrated to be effective in lowering HTT mRNA; however, the blood–brain barrier (BBB) poses a significant challenge for gene delivery to the brain. Delivery strategies include direct injections into the central nervous system, which are invasive and can result in poor diffusion of viral particles through the brain parenchyma. Focused ultrasound (FUS) is an alternative approach that can be used to non-invasively deliver AAVs by temporarily disrupting the BBB. Here, we investigate FUS-mediated delivery of a single-stranded AAV9 bearing a cDNA for GFP in 2-month-old wild-type mice and the zQ175 HD mouse model at 2-, 6-, and 12-months. FUS treatment improved AAV9 delivery for all mouse groups. The delivery efficacy was similar for all WT and HD groups, with the exception of the zQ175 12-month cohort, where we observed decreased GFP expression. Astrocytosis did not increase after FUS treatment, even within the zQ175 12-month group exhibiting higher baseline levels of GFAP expression. These findings demonstrate that FUS can be used to non-invasively deliver an AAV9-based gene therapy to targeted brain regions in a mouse model of Huntington's disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Nucleoside Reverse Transcriptase Inhibitor Exposure Is Associated with Lower Alzheimer's Disease Risk: A Retrospective Cohort Proof-of-Concept Study.
- Author
-
Chow, Tiffany W., Raupp, Mark, Reynolds, Matthew W., Li, Siying, Kaeser, Gwendolyn E., and Chun, Jerold
- Subjects
NUCLEOSIDE reverse transcriptase inhibitors ,DISEASE risk factors ,DONEPEZIL ,HIV ,ALZHEIMER'S disease ,COMMON cold - Abstract
Brain somatic gene recombination (SGR) and the endogenous reverse transcriptases (RTs) that produce it have been implicated in the etiology of Alzheimer's disease (AD), suggesting RT inhibitors as novel prophylactics or therapeutics. This retrospective, proof-of-concept study evaluated the incidence of AD in people with human immunodeficiency virus (HIV) with or without exposure to nucleoside RT inhibitors (NRTIs) using de-identified medical claims data. Eligible participants were aged ≥60 years, without pre-existing AD diagnoses, and pursued medical services in the United States from October 2015 to September 2016. Cohorts 1 (N = 46,218) and 2 (N = 32,923) had HIV. Cohort 1 had prescription claims for at least one NRTI within the exposure period; Cohort 2 did not. Cohort 3 (N = 150,819) had medical claims for the common cold without evidence of HIV or antiretroviral therapy. The cumulative incidence of new AD cases over the ensuing 2.75-year observation period was lowest in patients with NRTI exposure and highest in controls. Age- and sex-adjusted hazard ratios showed a significantly decreased risk for AD in Cohort 1 compared with Cohorts 2 (HR 0.88, p < 0.05) and 3 (HR 0.84, p < 0.05). Sub-grouping identified a decreased AD risk in patients with NRTI exposure but without protease inhibitor (PI) exposure. Prospective clinical trials and the development of next-generation agents targeting brain RTs are warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Bortezomib in Combination with Physachenolide C Reduces the Tumorigenic Properties of KRAS mut /P53 mut Lung Cancer Cells by Inhibiting c-FLIP.
- Author
-
Kanagasabai, Thanigaivelan, Dunbar, Zerick, Ochoa, Salvador González, Farris, Tonie, Dhandayuthapani, Sivanesan, Wijeratne, E. M. Kithsiri, Gunatilaka, A. A. Leslie, and Shanker, Anil
- Subjects
THERAPEUTIC use of antineoplastic agents ,PROTEINS ,IN vitro studies ,BIOLOGICAL models ,COMBINATION drug therapy ,BIOLOGICAL products ,ANIMAL experimentation ,OXYGEN consumption ,LUNG tumors ,BORTEZOMIB ,CANCER patients ,CELL survival ,CELL motility ,COMPARATIVE studies ,STEM cells ,TOXICITY testing ,DRUG synergism ,DESCRIPTIVE statistics ,RESEARCH funding ,CELL lines ,MICE ,TRANSPLANTATION of organs, tissues, etc. - Abstract
Simple Summary: c-FLIP is a master anti-apoptotic regulator associated with resistance to various therapeutic options in different cancer types. Thus, exploring the combinatorial antitumor effects of a natural product, physachenolide C (PCC) and bortezomib, could lead to an effective, non-toxic therapeutic regimen against KRAS
mut /P53mut lung cancer cells. Our results showed that the bortezomib–PCC combination was more effective in reducing the viability and inhibiting migration and invasion of cancer cells. Additionally, c-FLIP protein expression was significantly inhibited along with a substantial reduction in the critical parameters of cellular metabolism in cancer cells. Strikingly, tumor growth inhibition was much more effective in tumor xenograft mice models with an enhanced efficacy without causing significant side effects. Background: Defects in apoptosis regulation are one of the classical features of cancer cells, often associated with more aggressiveness and failure to therapeutic options. We investigated the combinatorial antitumor effects of a natural product, physachenolide C (PCC) and bortezomib, in KRASmut /P53mut lung cancer cells and xenograft mice models. Methods: The in vitro anticancer effects of the bortezomib and PCC combination were investigated using cell viability, migration, and invasion assays in 344SQ, H23, and H358 cell lines. Furthermore, the effects of combination treatment on the critical parameters of cellular metabolism, including extracellular acidification rate (ECAR) and mitochondrial oxidative phosphorylation based on the oxygen consumption rate of cancer cells were assessed using Seahorse assay. Finally, the antitumor effect of the bortezomib (1 mg/kg) and PCC (10 mg/kg) combination was evaluated using xenograft mice models. Results: Our data showed that the bortezomib–PCC combination was more effective in reducing the viability of lung cancer cells in comparison with the individual treatments. Similarly, the combination treatment showed a significant inhibition of cell migration and invasion of cancer cells. Additionally, the key anti-apoptotic protein c-FLIP was significantly inhibited along with a substantial reduction in the key parameters of cellular metabolism in cancer cells. Notably, the bortezomib or PCC inhibited the tumor growth compared to the control group, the tumor growth inhibition was much more effective when bortezomib was combined with PCC in tumor xenograft mice models. Conclusion: These findings demonstrate that PCC sensitizes cancer cells to bortezomib, potentially improving the antitumor effects against KRASmut /P53mut lung cancer cells, with an enhanced efficacy of combination treatments without causing significant side effects. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
7. Molecular Characteristics and Pathogenicity of Staphylococcus aureus Exotoxins.
- Author
-
Zhu, Zhihao, Hu, Zuo, Li, Shaowen, Fang, Rendong, Ono, Hisaya K., and Hu, Dong-Liang
- Subjects
TOXIC shock syndrome ,SKIN infections ,STAPHYLOCOCCUS aureus ,FOOD poisoning ,MOLECULAR structure ,COMMUNICABLE diseases ,POISONING - Abstract
Staphylococcus aureus stands as one of the most pervasive pathogens given its morbidity and mortality worldwide due to its roles as an infectious agent that causes a wide variety of diseases ranging from moderately severe skin infections to fatal pneumonia and sepsis. S. aureus produces a variety of exotoxins that serve as important virulence factors in S. aureus-related infectious diseases and food poisoning in both humans and animals. For example, staphylococcal enterotoxins (SEs) produced by S. aureus induce staphylococcal foodborne poisoning; toxic shock syndrome toxin-1 (TSST-1), as a typical superantigen, induces toxic shock syndrome; hemolysins induce cell damage in erythrocytes and leukocytes; and exfoliative toxin induces staphylococcal skin scalded syndrome. Recently, Panton–Valentine leucocidin, a cytotoxin produced by community-associated methicillin-resistant S. aureus (CA-MRSA), has been reported, and new types of SEs and staphylococcal enterotoxin-like toxins (SEls) were discovered and reported successively. This review addresses the progress of and novel insights into the molecular structure, biological activities, and pathogenicity of both the classic and the newly identified exotoxins produced by S. aureus. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. PolyQ-Expansion Causes Mitochondria Fragmentation Independent of Huntingtin and Is Distinct from Traumatic Brain Injury (TBI)/Mechanical Stress-Mediated Fragmentation Which Results from Cell Death.
- Author
-
Swinter, Kelsey, Salah, Dania, Rathnayake, Rasika, and Gunawardena, Shermali
- Subjects
BRAIN injuries ,CELL death ,PHYSIOLOGY ,HUNTINGTON disease ,HOMEOSTASIS ,STRAINS & stresses (Mechanics) - Abstract
Mitochondrial dysfunction has been reported in many Huntington's disease (HD) models; however, it is unclear how these defects occur. Here, we test the hypothesis that excess pathogenic huntingtin (HTT) impairs mitochondrial homeostasis, using Drosophila genetics and pharmacological inhibitors in HD and polyQ-expansion disease models and in a mechanical stress-induced traumatic brain injury (TBI) model. Expression of pathogenic HTT caused fragmented mitochondria compared to normal HTT, but HTT did not co-localize with mitochondria under normal or pathogenic conditions. Expression of pathogenic polyQ (127Q) alone or in the context of Machado Joseph Disease (MJD) caused fragmented mitochondria. While mitochondrial fragmentation was not dependent on the cellular location of polyQ accumulations, the expression of a chaperone protein, excess of mitofusin (MFN), or depletion of dynamin-related protein 1 (DRP1) rescued fragmentation. Intriguingly, a higher concentration of nitric oxide (NO) was observed in polyQ-expressing larval brains and inhibiting NO production rescued polyQ-mediated fragmented mitochondria, postulating that DRP1 nitrosylation could contribute to excess fission. Furthermore, while excess PI3K, which suppresses polyQ-induced cell death, did not rescue polyQ-mediated fragmentation, it did rescue fragmentation caused by mechanical stress/TBI. Together, our observations suggest that pathogenic polyQ alone is sufficient to cause DRP1-dependent mitochondrial fragmentation upstream of cell death, uncovering distinct physiological mechanisms for mitochondrial dysfunction in polyQ disease and mechanical stress. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Reactive Oxygen Species: A Crosslink between Plant and Human Eukaryotic Cell Systems.
- Author
-
Guo, Wei, Xing, Yadi, Luo, Xiumei, Li, Fuguang, Ren, Maozhi, and Liang, Yiming
- Subjects
REACTIVE oxygen species ,EUKARYOTIC cells ,AGRICULTURE - Abstract
Reactive oxygen species (ROS) are important regulating factors that play a dual role in plant and human cells. As the first messenger response in organisms, ROS coordinate signals in growth, development, and metabolic activity pathways. They also can act as an alarm mechanism, triggering cellular responses to harmful stimuli. However, excess ROS cause oxidative stress-related damage and oxidize organic substances, leading to cellular malfunctions. This review summarizes the current research status and mechanisms of ROS in plant and human eukaryotic cells, highlighting the differences and similarities between the two and elucidating their interactions with other reactive substances and ROS. Based on the similar regulatory and metabolic ROS pathways in the two kingdoms, this review proposes future developments that can provide opportunities to develop novel strategies for treating human diseases or creating greater agricultural value. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. The Effect of Different Glucose Concentrations on the Antiproliferative Activity of Metformin in MCF-7 Breast Cancer Cells.
- Author
-
Nurzhan, Sholpan, Bekezhankyzy, Zhibek, Ding, Hong, Berdigaliyev, Nurken, Sergazy, Shynggys, Gulyayev, Alexander, Shulgau, Zarina, Triggle, Christopher R., and Aljofan, Mohamad
- Subjects
METFORMIN ,CANCER cells ,BREAST cancer ,CELL proliferation ,BREAST ,PROTEIN expression ,GLUCOSE - Abstract
The glucose-lowering drug metformin has been reported to have anticancer properties through unknown mechanisms. Other unknown factors that may influence its anticancer potential include the glycemic status of the patient. Therefore, the objective of this study is to determine the effect of different glucose environments on the antiproliferative potency and the cellular mechanism of action of metformin. Human breast cancer cells, MCF-7, were incubated in low, normal, elevated, and high glucose environments and treated with metformin. The antiproliferative potential of metformin and its effect on protein expression as well as its ability to induce cellular apoptosis and autophagy under different glucose environments, were determined using different molecular techniques. Metformin significantly inhibited cellular proliferation in a time- and glucose-concentration-dependent manner. In comparison to elevated glucose, low normal glucose alone induced a significant level of autophagy that was further increased in the presence of metformin. While glucose concentration did not appear to have an effect on the antiproliferative potency of metformin, the cellular basis of action was shown to be glucose-dependent. The antiproliferative mechanism of action of metformin in elevated and low normal glucose environments is mTOR-dependent, whereas, in the high glucose environment, the antiproliferative mechanism is independent of mTOR. This is the first study to report that both the antiproliferative potency and the cellular mechanism of action aredependent on the concentration of glucose. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. The Impact of COVID-19 on People Living with HIV-1 and HIV-1-Associated Neurological Complications.
- Author
-
Dutta, Debashis, Liu, Jianuo, and Xiong, Huangui
- Subjects
SARS-CoV-2 ,NEUROLOGIC manifestations of general diseases ,COVID-19 ,HIV - Abstract
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative pathogen of the coronavirus disease 2019 (COVID-19) pandemic, a fatal respiratory illness. The associated risk factors for COVID-19 are old age and medical comorbidities. In the current combined antiretroviral therapy (cART) era, a significant portion of people living with HIV-1 (PLWH) with controlled viremia is older and with comorbidities, making these people vulnerable to SARS-CoV-2 infection and COVID-19-associated severe outcomes. Additionally, SARS-CoV-2 is neurotropic and causes neurological complications, resulting in a health burden and an adverse impact on PLWH and exacerbating HIV-1-associated neurocognitive disorder (HAND). The impact of SARS-CoV-2 infection and COVID-19 severity on neuroinflammation, the development of HAND and preexisting HAND is poorly explored. In the present review, we compiled the current knowledge of differences and similarities between SARS-CoV-2 and HIV-1, the conditions of the SARS-CoV-2/COVID-19 and HIV-1/AIDS syndemic and their impact on the central nervous system (CNS). Risk factors of COVID-19 on PLWH and neurological manifestations, inflammatory mechanisms leading to the neurological syndrome, the development of HAND, and its influence on preexisting HAND are also discussed. Finally, we have reviewed the challenges of the present syndemic on the world population, with a particular emphasis on PLWH. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. The Meeting of Micropeptides with Major Ca 2+ Pumps in Inner Membranes—Consideration of a New Player, SERCA1b.
- Author
-
Zádor, Ernő
- Published
- 2023
- Full Text
- View/download PDF
13. Cellular Targets of HIV-1 Protease: Just the Tip of the Iceberg?
- Author
-
Centazzo, Matteo, Manganaro, Lara, and Alvisi, Gualtiero
- Subjects
HIV ,VIRUS-induced enzymes ,GENETIC translation ,LIFE cycles (Biology) ,VIRAL genes ,CELL survival - Abstract
Human immunodeficiency virus 1 (HIV-1) viral protease (PR) is one of the most studied viral enzymes and a crucial antiviral target. Despite its well-characterized role in virion maturation, an increasing body of research is starting to focus on its ability to cleave host cell proteins. Such findings are apparently in contrast with the dogma of HIV-1 PR activity being restricted to the interior of nascent virions and suggest catalytic activity within the host cell environment. Given the limited amount of PR present in the virion at the time of infection, such events mainly occur during late viral gene expression, mediated by newly synthesized Gag-Pol polyprotein precursors, rather than before proviral integration. HIV-1 PR mainly targets proteins involved in three different processes: those involved in translation, those controlling cell survival, and restriction factors responsible for innate/intrinsic antiviral responses. Indeed, by cleaving host cell translation initiation factors, HIV-1 PR can impair cap-dependent translation, thus promoting IRES-mediated translation of late viral transcripts and viral production. By targeting several apoptotic factors, it modulates cell survival, thus promoting immune evasion and viral dissemination. Additionally, HIV-1 PR counteracts restriction factors incorporated in the virion that would otherwise interfere with nascent virus vitality. Thus, HIV-1 PR appears to modulate host cell function at different times and locations during its life cycle, thereby ensuring efficient viral persistency and propagation. However, we are far from having a complete picture of PR-mediated host cell modulation, which is emerging as a field that needs further investigation. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
14. NKG2A Immune Checkpoint in Vδ2 T Cells: Emerging Application in Cancer Immunotherapy.
- Author
-
Cazzetta, Valentina, Depierreux, Delphine, Colucci, Francesco, Mikulak, Joanna, and Mavilio, Domenico
- Subjects
TUMOR treatment ,IMMUNE checkpoint inhibitors ,CELL receptors ,IMMUNOMODULATORS ,KILLER cells ,CELL physiology ,MONOCLONAL antibodies ,GENE expression ,T cells ,CELL lines ,IMMUNOTHERAPY - Abstract
Simple Summary: Boosting effector T cell anti-tumor response remains a challenge, in part owing to the expression of immune checkpoints and their ligands, such as NKG2A and HLA-E. Targeting NKG2A by gene knockout or blocking antibodies improves the cytotoxicity of Vδ2 T cells, a specific subset of human unconventional γδ T lymphocytes. Thus, a suitable selection of NKG2A
+ or NKG2A− Vδ2 T cells for expansion or engineering could help to narrow the Vδ2 T cell population according to the expression of HLA-E on tumor cells. With this emerging knowledge, approaches to target NKG2A in Vδ2 T cells might be a promising step forward to boosting Vδ2 T cell-based cancer immunotherapies. Immune regulation has revolutionized cancer treatment with the introduction of T-cell-targeted immune checkpoint inhibitors (ICIs). This successful immunotherapy has led to a more complete view of cancer that now considers not only the cancer cells to be targeted and destroyed but also the immune environment of the cancer cells. Current challenges associated with the enhancement of ICI effects are increasing the fraction of responding patients through personalized combinations of multiple ICIs and overcoming acquired resistance. This requires a complete overview of the anti-tumor immune response, which depends on a complex interplay between innate and adaptive immune cells with the tumor microenvironment. The NKG2A was revealed to be a key immune checkpoint for both Natural Killer (NK) cells and T cells. Monalizumab, a humanized anti-NKG2A antibody, enhances NK cell activity against various tumor cells and rescues CD8 αβ T cell function in combination with PD-1/PD-L1 blockade. In this review, we discuss the potential for targeting NKG2A expressed on tumor-sensing human γδ T cells, mostly on the specific Vδ2 T cell subset, in order to emphasize its importance and potential in the development of new ICI-based therapeutic approaches. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
15. Disease correction in mucopolysaccharidosis type IIIB mice by intraparenchymal or cisternal delivery of a capsid modified AAV8 codon-optimized NAGLU vector.
- Author
-
Rouse, Courtney J, Hawkins, Kimberley, Kabbej, Nadia, Dalugdug, Justin, Kunta, Aishwarya, Kim, Mi-Jung, Someya, Shinichi, Herbst, Zachary, Gelb, Michael, Dinelli, Isabella, Butterworth, Elizabeth, Falk, Darin J, Rosenkrantz, Erinn, Elmohd, Hamza, Khaledi, Hamid, Mowafy, Samar, Ashby, Frederick, and Heldermon, Coy D
- Published
- 2023
- Full Text
- View/download PDF
16. On the Sustainability of Shared Mobility Since COVID-19: From Socially Structured to Social Bubble Vanpooling.
- Author
-
Haddad, Hedi, Bouyahia, Zied, and Horchani, Leila
- Abstract
Public and shared transportation are among the sectors that have been severely affected by the COVID-19 pandemic, as they were perceived to be risky environments for disease transmission. Given that the end of the pandemic is not certain and in order to anticipate future pandemics, attempts have been made to design public and shared mobility systems that are pandemic resilient, avoiding the social and economic burdens of disrupting transportation services. In this paper, we introduce a new ridesharing form based on a novel concept called social bubble vanpooling (SBV) which tries to provide a trade-off between minimizing the risk of exposure of riders to communicable diseases, minimizing the operational costs of ridesharing operators, and providing public health authorities with full contact-tracing capability in ridesharing-related cases, if needed. We propose a new clustering approach where riders are pooled into social bubbles composed of people who are spatio-temporally connected and have similar vulnerability levels with respect to a communicable diseases. We used individual agent-based simulation experiments based on a data sample collected from a real population of riders, and we compared the performance of the proposed SBV with trip-based and long committed ridesharing models. We found that (1) enforcing contact tracing and quarantine is more effective in controlling the spread of the disease when the bubble-based ridesharing scheme is adopted as a commuting mode and (2) it is possible to sustain transportation services without compromising the efforts to mitigate the spread of the pandemic. The proposed ridesharing model appears to be a viable solution when the mobility of individuals is subject to tight restrictions to stop the spread of a communicable airborne disease (such as COVID-19). The flexibility of the model allows maintaining transportation services with profitable operational costs while upholding the precautionary measures to fight the pandemic. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
17. dNAGLU Extends Life Span and Promotes Fitness and Stress Resistance in Drosophila.
- Author
-
Xue, Rubing, Yang, Ke, Xiao, Fuhui, Yang, Liping, Chen, Guijun, Li, Yongxuan, Ye, Yunshuang, Chen, Kangning, Smith, Sheryl T., Li, Gonghua, Kong, Qingpeng, and Zhou, Jumin
- Subjects
LONGEVITY ,LIFE spans ,DROSOPHILA ,ALZHEIMER'S disease ,CENTRAL nervous system ,NERVOUS system ,AMYLOID beta-protein precursor - Abstract
To identify new factors that promote longevity and healthy aging, we studied Drosophila CG13397, an ortholog of the human NAGLU gene, a lysosomal enzyme overexpressed in centenarians. We found that the overexpression of CG13397 (dNAGLU) ubiquitously, or tissue specifically, in the nervous system or fat body could extend fly life span. It also extended the life span of flies overexpressing human Aβ42, in a Drosophila Alzheimer's disease (AD) model. To investigate whether dNAGLU could influence health span, we analyzed the effect of its overexpression on AD flies and found that it improved the climbing ability and stress resistance, including desiccation and hunger, suggesting that dNAGLU improved fly health span. We found that the deposition of Aβ42 in the mushroom body, which is the fly central nervous system, was reduced, and the lysosomal activity in the intestine was increased in dNAGLU over-expressing flies. When NAGLU was overexpressed in human U251-APP cells, which expresses a mutant form of the Aβ-precursor protein (APP), APP-p.M671L, these cells exhibited stronger lysosomal activity and and enhanced expression of lysosomal pathway genes. The concentration of Aβ42 in the cell supernatant was reduced, and the growth arrest caused by APP expression was reversed, suggesting that NAGLU could play a wider role beyond its catalytic activity to enhance lysosomal activity. These results also suggest that NAGLU overexpression could be explored to promote healthy aging and to prevent the onset of neurodegenerative diseases, including AD. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. First Genome-Based Characterisation and Staphylococcal Enterotoxin Production Ability of Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Strains Isolated from Ready-to-Eat Foods in Algiers (Algeria).
- Author
-
Fanelli, Francesca, Chieffi, Daniele, Cho, Gyu-Sung, Schubert, Justyna, Mekhloufi, Omar Amine, Bania, Jacek, Franz, Charles M. A. P., and Fusco, Vincenzina
- Subjects
METHICILLIN-resistant staphylococcus aureus ,ENTEROTOXINS ,TOXIC shock syndrome ,MUPIROCIN ,STAPHYLOCOCCUS aureus ,PATHOGENIC microorganisms ,PSEUDOGENES - Abstract
Staphylococcus aureus is a pathogenic microorganism of humans and animals, able to cause foodborne intoxication due to the production of staphylococcal enterotoxins (SEs) and to resist antibiotic treatment as in the case of methicillin-resistant S. aureus (MRSA). In this study, we performed a genomic characterisation of 12 genetically diverse S. aureus strains isolated from ready-to-eat foods in Algiers (Algeria). Moreover, their ability to produce some classical and new staphylococcal enterotoxins (SEs) was investigated. The 12 S. aureus strains resulted to belong to nine known sequence types (STs) and to the novel ST7199 and ST7200. Furthermore, S. aureus SA46 was assigned to the European clone MRSA-ST80-SCCmec-IV. The 12 strains showed a wide endowment of se and sel (staphylococcal enterotoxin-like toxin) genes (sea, seb, sed, seg, seh, sei, selj, sek, sem, sen, seo, seq, ser, selu2, selw, selx, sey, sel30; ψent1-ψent2), including variants and pseudogenes, and harboured the enterotoxin gene cluster (egc) types 1 and 5. Additionally, they produced various amounts of SEA (64.54–345.02 ng/mL), SEB (2871.28–14739.17 ng/mL), SED (322.70–398.94 ng/mL), SEH (not detectable–239.48 ng/mL), and SER (36,720.10–63,176.06 ng/mL) depending on their genotypes. The genetic determinants related to their phenotypic resistance to β-lactams (blaZ, mecA), ofloxacin (gyrA-S84L), erythromycin (ermB), lincomycin (lmrS), kanamycin (aph(3′)-III, ant(6)-I), and tetracyclin (tet(L), tet(38)) were also detected. A plethora of virulence-related genes, including major virulence genes such as the tst gene, determinant for the toxic shock syndrome toxin-1, and the lukF-PV and lukS-PV genes, encoding the panton-valentine leukocidin (PVL), were present in the S. aureus strains, highlighting their pathogenic potential. Furthermore, a phylogenomic reconstruction including worldwide foodborne S. aureus showed a clear clustering based on ST and geographical origin rather than the source of isolation. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
19. Increased CD4 + CD8 + Double Positive T Cells during Hantaan Virus Infection.
- Author
-
Zhang, Huiyuan, Wang, Yazhen, Ma, Ying, Tang, Kang, Zhang, Chunmei, Wang, Meng, Zhang, Xiyue, Xue, Manling, Jia, Xiaozhou, Hu, Haifeng, Li, Na, Zhuang, Ran, Jin, Boquan, Chen, Lihua, Zhang, Yun, and Zhang, Yusi
- Subjects
HEMORRHAGIC fever with renal syndrome ,VIRUS diseases ,CD8 antigen ,GENE expression profiling ,CD4 antigen ,CYTOTOXIC T cells - Abstract
Hantaan virus (HTNV) infection causes an epidemic of hemorrhagic fever with renal syndrome (HFRS) mainly in Asia. It is well known that T cells mediated anti-viral immune response. Although previous studies showed that double positive T (DP T) cells, a little portion of T lymphocytes, were involved in adaptive immune response during virus infection, their kinetic changes and roles in HTNV infection have not yet been explored. In this study, we characterized DP T cells from HFRS patients based on flow cytometry data combined with scRNA-seq data. We showed that HTNV infection caused the upregulation of DP T cells in the peripheral blood, which were correlated with disease stage. The scRNA-seq data clustered DP T cells, unraveled their gene expression profile, and estimated the ordering of these cells. The production of granzyme B and CD107a from DP T cells and the abundant TCR distribution indicated the anti-viral property of DP T cells. In conclusion, this study identified, for the first time, an accumulation of DP T cells in the peripheral blood of HFRS patients and suggested these DP T cells belonging to CD8
+ T cells lineage. The DP T cells shared the similar characteristics with cytotoxic T cells (CTL) and exerted an anti-viral role in HFRS. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
20. Two Distinct Mechanisms Underlying γδ T Cell-Mediated Regulation of Collagen Type I in Lung Fibroblasts.
- Author
-
Okuno, Daisuke, Sakamoto, Noriho, Akiyama, Yoshiko, Tokito, Takatomo, Hara, Atsuko, Kido, Takashi, Ishimoto, Hiroshi, Ishimatsu, Yuji, Tagod, Mohammed S. O., Okamura, Haruki, Tanaka, Yoshimasa, and Mukae, Hiroshi
- Subjects
FIBROBLASTS ,IDIOPATHIC pulmonary fibrosis ,COLLAGEN ,T cells ,LUNGS ,INTERLEUKIN-2 - Abstract
Idiopathic pulmonary fibrosis is a chronic intractable lung disease, leading to respiratory failure and death. Although anti-fibrotic agents delay disease progression, they are not considered curative treatments, and alternative modalities have attracted attention. We examined the effect of human γδ T cells on collagen type I in lung fibroblasts. Collagen type I was markedly reduced in a γδ T cell number-dependent manner following treatment with γδ T cells expanded with tetrakis-pivaloxymethyl 2-(thiazole-2-ylamino) ethylidene-1,1-bisphosphonate (PTA) and interleukin-2. Collagen type I levels remained unchanged on addition of γδ T cells to the culture system through a trans-well culture membrane, suggesting that cell–cell contact is essential for reducing its levels in lung fibroblasts. Re-stimulating γδ T cells with (E)-4-hydroxy-3-methylbut-2-enyl diphosphate (HMBPP) reduced collagen type I levels without cell–cell contact, indicating the existence of HMBPP-induced soluble anti-fibrotic factors in γδ T cells. Adding anti-interferon-γ (IFN-γ)-neutralizing mAb restored collagen type I levels, demonstrating that human γδ T cell-derived IFN-γ reduces collagen type I levels. Conversely, interleukin-18 augmented γδ T cell-induced suppression of collagen type I. Therefore, human γδ T cells reduce collagen levels in lung fibroblasts via two distinct mechanisms; adoptive γδ T cell transfer is potentially a new therapeutic candidate. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
21. Functional and Immunological Studies Revealed a Second Superantigen Toxin in Staphylococcal Enterotoxin C Producing Staphylococcus aureus Strains.
- Author
-
Roetzer, Andreas, Model, Nina, Laube, Jakob, Unterhumer, Yvonne, Haller, Guenter, and Eibl, Martha M.
- Subjects
EXOTOXIN ,ENTEROTOXINS ,STAPHYLOCOCCUS aureus ,TOXIC shock syndrome ,TOXINS ,SEPTIC shock ,GENOMICS - Abstract
Staphylococcus aureus is a human and animal pathogen as well as a commensal bacterium. It can be a causative agent of severe, life-threatening infections with high mortality, e.g., toxic shock syndrome, septic shock, and multi-organ failure. S. aureus strains secrete a number of toxins. Exotoxins/enterotoxins are considered important in the pathogenesis of the above-mentioned conditions. Exotoxins, e.g., superantigen toxins, cause uncontrolled and polyclonal T cell activation and unregulated activation of inflammatory cytokines. Here we show the importance of genomic analysis of infectious strains in order to identify disease-causing exotoxins. Further, we show through functional analysis of superantigenic properties of staphylococcal exotoxins that even very small amounts of a putative superantigenic contaminant can have a significant mitogenic effect. The results show expression and production of two distinct staphylococcal exotoxins, SEC and SEL, in several strains from clinical isolates. Antibodies against both toxins are required to neutralise the superantigenic activity of staphylococcal supernatants and purified staphylococcal toxins. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
22. The Shigella Vaccines Pipeline.
- Author
-
MacLennan, Calman Alexander, Grow, Stephanie, Ma, Lyou-fu, and Steele, Andrew Duncan
- Subjects
SHIGELLA ,VACCINE development ,VACCINES ,CARRIER proteins ,MIDDLE-income countries - Abstract
Shigella is the leading cause of global diarrheal deaths that currently lacks a licensed vaccine. Shigellosis drives antimicrobial resistance and leads to economic impact through linear growth faltering. Today, there is a robust pipeline of vaccines in clinical development which are broadly divided into parenteral glycoconjugate vaccines, consisting of O-antigen conjugated to carrier proteins, and oral live attenuated vaccines, which incorporate targeted genetic mutations seeking to optimize the balance between reactogenicity, immunogenicity and ultimately protection. Proof of efficacy has previously been shown with both approaches but for various reasons no vaccine has been licensed to date. In this report, we outline the requirements for a Shigella vaccine and describe the current pipeline in the context of the many candidates that have previously failed or been abandoned. The report refers to papers from individual vaccine developers in this special supplement of Vaccines which is focused on Shigella vaccines. Once readouts of safety and immunogenicity from current trials of lead candidate vaccines among the target population of young children in low- and middle-income countries are available, the likely time to licensure of a first Shigella vaccine will become clearer. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
23. World on Data Perspective.
- Author
-
Nasution, Mahyuddin K. M.
- Subjects
COVID-19 pandemic ,ARTIFICIAL intelligence ,COVID-19 vaccines - Abstract
It is not simple to consider the world from only one side, but analyzing all sides can cloud comprehension without reaching deep insight found at the core. In a word as a whole, there is potential for telling the whole world in one word, i.e., data, leading to interpretations as phenomena and paradigms at the core of this review. The tug of war between the two sides explains that data represent the world, or vice versa, and present a fundamental view that systems or subsystems frame the world, even though they are encoded and composed of culture, rules, or approaches such as the threshold of democracy. When the COVID-19 pandemic posed a threat, human efforts contributed to finding potentially answers to questions presented by the world: what, who, where, when, why, and how (5 wh); a calling in the form of a challenge, where facts show something. All these questions resulted in research, education, and service activities, with their respective data frameworks producing results. This paper aims to reveal the meaning of the outcomes through an observation from an outside perspective. Therefore, like COVID-19 and its vaccines, the assertion of convexity and concave contradictions in the treatment of data leads to a mutually conjugate treatment of data. In this regard, statistics and artificial intelligence play separate and complementary roles. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
24. Occult Hepatitis B Virus Infection: An Update.
- Author
-
Saitta, Carlo, Pollicino, Teresa, and Raimondo, Giovanni
- Subjects
HEPATITIS B ,VIRUS diseases ,CIRCULAR DNA ,HEPATITIS B virus ,CELL surface antigens ,VIRAL DNA - Abstract
Occult hepatitis B virus (HBV) infection (OBI) refers to a condition in which replication-competent viral DNA is present in the liver (with detectable or undetectable HBV DNA in the serum) of individuals testing negative for the HBV surface antigen (HBsAg). In this peculiar phase of HBV infection, the covalently closed circular DNA (cccDNA) is in a low state of replication. Many advances have been made in clarifying the mechanisms involved in such a suppression of viral activity, which seems to be mainly related to the host's immune control and epigenetic factors. OBI is diffused worldwide, but its prevalence is highly variable among patient populations. This depends on different geographic areas, risk factors for parenteral infections, and assays used for HBsAg and HBV DNA detection. OBI has an impact in several clinical contexts: (a) it can be transmitted, causing a classic form of hepatitis B, through blood transfusion or liver transplantation; (b) it may reactivate in the case of immunosuppression, leading to the possible development of even fulminant hepatitis; (c) it may accelerate the progression of chronic liver disease due to different causes toward cirrhosis; (d) it maintains the pro-oncogenic properties of the "overt" infection, favoring the development of hepatocellular carcinoma. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
25. A Historical Review of Brain Drug Delivery.
- Author
-
Pardridge, William M.
- Subjects
BLOOD-brain barrier ,DRUG delivery systems ,SMALL molecules ,GENE therapy ,STEM cells - Abstract
The history of brain drug delivery is reviewed beginning with the first demonstration, in 1914, that a drug for syphilis, salvarsan, did not enter the brain, due to the presence of a blood–brain barrier (BBB). Owing to restricted transport across the BBB, FDA-approved drugs for the CNS have been generally limited to lipid-soluble small molecules. Drugs that do not cross the BBB can be re-engineered for transport on endogenous BBB carrier-mediated transport and receptor-mediated transport systems, which were identified during the 1970s–1980s. By the 1990s, a multitude of brain drug delivery technologies emerged, including trans-cranial delivery, CSF delivery, BBB disruption, lipid carriers, prodrugs, stem cells, exosomes, nanoparticles, gene therapy, and biologics. The advantages and limitations of each of these brain drug delivery technologies are critically reviewed. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
26. Detection of Resistant and Enterotoxigenic Strains of Staphylococcus warneri Isolated from Food of Animal Origin.
- Author
-
Regecová, Ivana, Výrostková, Jana, Zigo, František, Gregová, Gabika, Pipová, Monika, Jevinová, Pavlina, and Becová, Jana
- Subjects
FOOD of animal origin ,CLINDAMYCIN ,OXACILLIN ,MOXIFLOXACIN ,LINEZOLID ,CHLORAMPHENICOL ,TETRACYCLINES ,TEICOPLANIN - Abstract
The topic of this work is the detection of antimicrobial resistance to Staphylococcus warneri strains and the genes encoding staphylococcal enterotoxins. It is considered a potential pathogen that can cause various—mostly inflammatory—diseases in immunosuppressed patients. The experimental part of the paper deals with the isolation of individual isolates from meat samples of Oryctolagus cuniculus, Oncorhynchus mykiss, Scomber scombrus, chicken thigh, beef thigh muscle, pork thigh muscle, and bryndza cheese. In total, 45 isolates were obtained and subjected to phenotypic (plasma coagulase activity, nuclease, pigment, hemolysis, lecithinase, and lipase production) and genotypic analyses to confirm the presence of the S. warneri species. The presence of genes encoding staphylococcal enterotoxins A (three isolates) and D (six isolates) was determined by PCR. Using the Miditech system, the minimum inhibitory concentration for various antibiotics or antibiotics combinations was determined, namely for ampicillin; ampicillin + sulbactam; oxacillin; cefoxitin; piperacillin + tazobactam; erythromycin; clindamycin; linezolid; rifampicin; gentamicin; teicoplanin; vancomycin; trimethoprim; chloramphenicol; tigecycline; moxifloxacin; ciprofloxacin; tetracycline; trimethoprim + sulfonamide; and nitrofurantoin. Resistance to ciprofloxacin and tetracycline was most common (73%). At the same time, out of a total of 45 isolates, 22% of the isolates were confirmed as multi-resistant. Isolates that showed phenotypic resistance to β-lactam antibiotics were subjected to mecA gene detection by PCR. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
27. Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma.
- Author
-
Wendlinger, Simone, Wohlfarth, Jonas, Kreft, Sophia, Siedel, Claudia, Kilian, Teresa, Dischinger, Ulrich, Heppt, Markus V., Wistuba-Hamprecht, Kilian, Meier, Friedegund, Goebeler, Matthias, Schadendorf, Dirk, Gesierich, Anja, Kosnopfel, Corinna, and Schilling, Bastian
- Subjects
EOSINOPHILS ,FLOW cytometry ,MELANOMA ,INDIVIDUALIZED medicine ,RETROSPECTIVE studies ,CANCER patients ,DESCRIPTIVE statistics ,TUMOR markers ,CELL lines ,LONGITUDINAL method ,PHENOTYPES - Abstract
Simple Summary: Despite the advances in treatment of patients diagnosed with advanced melanoma, long-term benefits remain limited due to primary and acquired resistance. Reliable biomarkers may support treatment decisions and should optimize treatment efficacy. By using a homogeneous population of melanoma patients, peripheral blood eosinophils, along with their cytotoxic potential and soluble markers, were evaluated for their suitability as biomarkers in patients receiving targeted therapy. High relative eosinophil (REC) counts correlated with the response to targeted therapy. In vitro experiments underlined these results showing high cytotoxicity of eosinophils towards melanoma cells, which was significantly enhanced by the addition of using targeted therapy agents. We also provide evidence of a bidirectional relationship between eosinophils and melanoma cells, which might further improve the treatment of advanced melanoma. Background: Eosinophils appear to contribute to the efficacy of immunotherapy and their frequency was suggested as a predictive biomarker. Whether this observation could be transferred to patients treated with targeted therapy remains unknown. Methods: Blood and serum samples of healthy controls and 216 patients with advanced melanoma were prospectively and retrospectively collected. Freshly isolated eosinophils were phenotypically characterized by flow cytometry and co-cultured in vitro with melanoma cells to assess cytotoxicity. Soluble serum markers and peripheral blood counts were used for correlative studies. Results: Eosinophil-mediated cytotoxicity towards melanoma cells, as well as phenotypic characteristics, were similar when comparing healthy donors and patients. However, high relative pre-treatment eosinophil counts were significantly associated with response to MAPKi (p = 0.013). Eosinophil-mediated cytotoxicity towards melanoma cells is dose-dependent and requires proximity of eosinophils and their target in vitro. Treatment with targeted therapy in the presence of eosinophils results in an additive tumoricidal effect. Additionally, melanoma cells affected eosinophil phenotype upon co-culture. Conclusion: High pre-treatment eosinophil counts in advanced melanoma patients were associated with a significantly improved response to MAPKi. Functionally, eosinophils show potent cytotoxicity towards melanoma cells, which can be reinforced by MAPKi. Further studies are needed to unravel the molecular mechanisms of our observations. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
28. Natural History and Molecular Characteristics of Korean Patients with Mucopolysaccharidosis Type III.
- Author
-
Kim, Min-Sun, Yang, Aram, Noh, Eu-seon, Kim, Chiwoo, Bae, Ga Young, Lim, Han Hyuk, Park, Hyung-Doo, Cho, Sung Yoon, and Jin, Dong-Kyu
- Subjects
SANFILIPPO syndrome ,KOREANS ,NATURAL history ,FRAGILE X syndrome ,ASIANS ,LYSOSOMAL storage diseases ,DEAD - Abstract
Background: Mucopolysaccharidosis type III (MPS III) is an autosomal recessive lysosomal storage disorder characterised by progressive neurocognitive deterioration. MPS III subtypes are clinically indistinguishable, with a wide range of symptoms and variable severity. The natural history of this disorder within an Asian population has not yet been extensively studied. This study investigated the natural history of Korean patients with MPS III. Methods: Thirty-four patients from 31 families diagnosed with MPS III from January 1997 to May 2020 in Samsung Medical Centre were enrolled. Clinical, molecular, and biochemical characteristics were retrospectively collected from the patients' medical records and via interviews. Results: 18 patients had MPS IIIA, 14 had IIIB, and two had IIIC. Twenty (58.9%) patients were male. Mean age at symptom onset was 2.8 ± 0.8 years and at diagnosis was 6.3 ± 2.2 years. All patients with MPS IIIA and IIIB were classified into the rapidly progressing (RP) phenotype. The most common symptom at diagnosis was language retardation (88.2%), followed by motor retardation (76.5%), general retardation (64.7%), and hyperactivity (41.2%). Language retardation was more predominant in IIIA, and motor retardation was more predominant in IIIB. The mean age of the 13 deceased patients at the time of the study was 14.4 ± 4.1 years. The age at diagnosis and lag time were significantly older and longer in the non-survivor group compared with the survivor group (p = 0.029 and 0.045, respectively). Genetic analysis was performed in 24 patients with MPS III and identified seven novel variants and three hot spots. Conclusion: This study is the first to analyse the genetic and clinical characteristics of MPS III patients in Korea. Better understanding of the natural history of MPS III might allow early diagnosis and timely management of the disease and evaluation of treatment outcomes in future clinical trials for MPS III. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
29. Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?
- Author
-
Horgan, Claire, Jones, Simon A., Bigger, Brian W., and Wynn, Robert
- Subjects
STEM cell treatment ,HEMATOPOIETIC stem cells ,MUCOPOLYSACCHARIDOSIS ,LYSOSOMAL storage diseases ,STEM cell transplantation ,LYSOSOMES - Abstract
Mucopolysaccharidosis type II (Hunter Syndrome) is a rare, x-linked recessive, progressive, multi-system, lysosomal storage disease caused by the deficiency of iduronate-2-sulfatase (IDS), which leads to the pathological storage of glycosaminoglycans in nearly all cell types, tissues and organs. The condition is clinically heterogeneous, and most patients present with a progressive, multi-system disease in their early years. This article outlines the pathology of the disorder and current treatment strategies, including a detailed review of haematopoietic stem cell transplant outcomes for MPSII. We then discuss haematopoietic stem cell gene therapy and how this can be employed for treatment of the disorder. We consider how preclinical innovations, including novel brain-targeted techniques, can be incorporated into stem cell gene therapy approaches to mitigate the neuropathological consequences of the condition. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
30. Detoxified O-Specific Polysaccharide (O-SP)–Protein Conjugates: Emerging Approach in the Shigella Vaccine Development Scene.
- Author
-
Cohen, Dani, Meron-Sudai, Shiri, Bialik, Anya, Asato, Valeria, and Ashkenazi, Shai
- Subjects
SHIGELLOSIS ,POLYSACCHARIDES ,VACCINE development ,SHIGELLA ,CARRIER proteins ,ORAL vaccines - Abstract
Shigella is the second most common cause of moderate to severe diarrhea among children worldwide and of diarrheal disease-associated mortality in young children in low-and middle-income countries. In spite of many years of attempts to develop Shigella vaccines, no licensed vaccines are yet available. Injectable conjugate vaccines made of the detoxified lipopolysaccharide (LPS) of S. flexneri 2a, S. sonnei, and S. dysenteriae type 1 covalently bound to protein carriers were developed in the early 1990s by John B. Robbins and Rachel Schneerson at the US National Institutes of Health. This approach was novel for a disease of the gut mucosa, at a time when live, rationally attenuated oral vaccine strains that intended to mimic Shigella infection and induce a protective local immune response were extensively investigated. Of keystone support to Shigella glycoconjugates development were the findings of a strong association between pre-existent serum IgG antibodies to S. sonnei or S. flexneri 2a LPS and a lower risk of infection with the homologous Shigella serotypes among Israeli soldiers serving in field units. In view of these findings and of the successful development of the pioneering Haemophilus influenzae type b conjugate vaccines, it was hypothesized that protective immunity may be conferred by serum IgG antibodies to the O-Specific Polysaccharide (O-SP) following parenteral delivery of the conjugates. S. sonnei and S. flexneri 2a glycoconjugates induced high levels of serum IgG against the homologous LPS in phase I and II studies in healthy volunteers. The protective efficacy of a S. sonnei detoxified LPS-conjugate was further demonstrated in field trials in young adults (74%) and in children older than three years of age (71%), but not in younger ones. The evaluation of the Shigella conjugates confirmed that IgG antibodies to Shigella LPS are correlates of protection and provided solid basis for the development of a new generation of glycoconjugates and other injectable LPS-based vaccines that are currently in advanced stages of clinical evaluation. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
31. Toward a Multivalent Synthetic Oligosaccharide-Based Conjugate Vaccine against Shigella : State-of-the-Art for a Monovalent Prototype and Challenges.
- Author
-
Phalipon, Armelle and Mulard, Laurence A.
- Subjects
SHIGELLA ,SHIGELLA flexneri ,CARRIER proteins ,CELL surface antigens ,VACCINES - Abstract
This review focuses on the molecular glycovaccine concept, a promising option to develop a Shigella glycoconjugate vaccine. Subsequent to original developments involving, as main vaccine component, the detoxified Shigella lipopolysaccharide randomly conjugated at multiple sites to a carrier protein, novelty stems from the use of rationally designed, well-defined chemically synthesized oligosaccharide haptens conceived as functional surrogates of the main surface antigen, linked via single-point attachment onto a carrier. The concept and design of such a fine-tuned Shigella glycovaccine are presented by way of SF2a-TT15, a neoglycoprotein featuring a synthetic 15-mer oligosaccharide, which constitutes an original vaccine prototype targeting Shigella flexneri 2a, one of the predominant circulating strains in endemic settings. The clinical testing of SF2a-TT15 is summarized with the first-in-human phase I trial in young healthy adults showing a good safety profile and tolerability, while inducing bactericidal antibodies towards S. flexneri 2a bacteria. The proof-of-concept of this novel approach being established, an ongoing phase IIa clinical study in the nine-month-old infant target population in endemic area was launched, which is also outlined. Lastly, some challenges to move forward this original approach toward a multivalent cost-effective Shigella synthetic glycan conjugate vaccine are introduced. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
32. Yellow Fever: Origin, Epidemiology, Preventive Strategies and Future Prospects.
- Author
-
Gianchecchi, Elena, Cianchi, Virginia, Torelli, Alessandro, and Montomoli, Emanuele
- Subjects
YELLOW fever ,VACCINATION coverage ,EPIDEMIOLOGY ,VACCINATION status ,VACCINE effectiveness - Abstract
Yellow fever (YF) virus still represents a major threat in low resource countries in both South America and Africa despite the presence of an effective vaccine. YF outbreaks are not only due to insufficient vaccine coverage for insufficient vaccine supply, but also to the increase in people without history of vaccination living in endemic areas. Globalization, continuous population growth, urbanization associated with inadequate public health infrastructure, and climate changes constitute important promoting factors for the spread of this virus to tropical and subtropical areas in mosquito-infested regions capable of spreading the disease. In the present review, we focus on the origin of the virus and its transmission, representing two debated topics throughout the nineteenth century, going deeply into the history of YF vaccines until the development of the vaccine still used nowadays. Besides surveillance, we highlight the urgent need of routine immunization and vaccination campaigns associated to diverse and innovative mosquito control technologies in endemic areas for YF virus in order to minimize the risk of new YF outbreaks and the global burden of YF in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
33. Identification of four caspase genes from Spodoptera exigua (Lepidoptera: Noctuidae) and their regulations toward different apoptotic stimulations.
- Author
-
Yu, Huan, Li, Zi‐Qi, Ou‐Yang, Yi‐Yi, and Huang, Guo‐Hua
- Subjects
BEET armyworm ,NOCTUIDAE ,MULTICELLULAR organisms ,CASPASES ,AMINO acid sequence ,LEPIDOPTERA ,SPODOPTERA littoralis - Abstract
Apoptosis plays critical roles in multiple biological processes in multicellular organisms. Caspases are known as important participators and regulators of apoptosis. Here, four novel caspase genes of Spodoptera exigua were cloned and characterized, which were designated as SeCasp‐1, SeCasp‐6, SeCasp‐7 and SeCasp‐8. Analysis of the putative encoded protein sequences of these SeCasps indicated that SeCasp‐1 and SeCasp‐7 were possible homologs of executor caspases; SeCasp‐8 was a possible homolog of initiator caspases; and SeCasp‐6 was a unique caspase of S. exigua that shares low similarity with all the identified insect caspases. Based on baculovirus expression system analyses, SeCasp‐1 exhibited similar caspase activity to human caspase‐1, ‐3, ‐4, ‐6, ‐8 and ‐9; SeCasp‐6 presented similar caspase activity to human caspase‐2, ‐3, ‐4, ‐6, ‐8 and ‐9; SeCasp‐7 exhibited similar caspase activity to human caspase‐2, ‐3 and ‐6; and SeCasp‐8 presented similar caspase activity only to human caspase‐8. Induction with different chemicals revealed that SeCasp‐1 showed extreme upregulation after 24 h in the treated fat body cell line (IOZCAS‐Spex‐II) of S. exigua. Developmental expression analysis revealed that SeCasp‐1 was highly transcribed in the larval stages, while SeCasp‐6, SeCasp‐7, SeCasp‐8 were down‐regulated. The in vivo detection of the relative expression levels of SeCasps in S. eixgua larvae inoculated with different pathogens suggested that SeCasp‐1 was sensitive to Bacillus thuringiensis infection and that SeCasp‐6 was sensitive to baculovirus infection. SeCasp‐7 and SeCasp‐8 showed slight changes under either in vitro chemical apoptosis induction or in vivo pathogen infection. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
34. VISDB: a manually curated database of viral integration sites in the human genome.
- Author
-
Tang, Deyou, Li, Bingrui, Xu, Tianyi, Hu, Ruifeng, Tan, Daqiang, Song, Xiaofeng, Jia, Peilin, and Zhao, Zhongming
- Published
- 2020
- Full Text
- View/download PDF
35. Physiopathologie de l'infection par le VIH-2.
- Author
-
Visseaux, Benoît, Le Hingrat, Quentin, Damond, Florence, Charpentier, Charlotte, and Descamps, Diane
- Subjects
HIV infections ,VIRAL replication ,EPIDEMIOLOGY ,VIRUSES ,INFECTION ,VIRAL load - Abstract
Résumé: Le virus du VIH-2 est peu répandu dans le monde, avec seulement un à trois millions de personnes infectées principalement en Afrique de l'Ouest. Le VIH-2 est aussi responsable d'une infection atténuée comparée à l'infection par le VIH-1. L'infection VIH-2 se caractérise ainsi par des charges virales faibles et fréquemment indétectables, ainsi que par une évolution plus lente vers le stade sida. Décrire les différences dans l'histoire naturelle de l'infection observées chez les patients infectés par l'un de ces deux virus, puis déterminer les mécanismes expliquant la moindre pathogénicité du VIH-2, est essentiel pour mieux comprendre l'infection VIH. Les études menées jusqu'à aujourd'hui ont permis d'identifier à la fois des facteurs liés à l'hôte et d'autres liées au virus concourant à la fois à un meilleur contrôle immunitaire et à une réplication virale atténuée. Dans cette revue, nous passons en revue l'origine et l'épidémiologie du VIH-2, l'histoire naturelle de l'infection, les principaux outils virologiques du suivi de l'infection et les principaux mécanismes identifiés expliquant l'infection atténuée du VIH-2. Nous indiquons aussi certains points restant encore à explorer. The HIV-2 virus is not widely spread worldwide, with only one to three million infected people, mainly in West Africa. HIV-2 is responsible for an attenuated infection compared to HIV-1. Thus, HIV-2 infection is characterized by low and frequently undetectable viral loads and a slower course to AIDS. Describing the infection natural history differences between these two viruses, and then determining the mechanisms underlying the HIV-2 lower pathogenicity, is essential to identify the mechanisms underlying the immunopathogenicity of HIV infection. Studies conducted to date have identified both host-related and virus-related factors contributing to an improved immune control and the attenuated viral replication. In this review, we summarize the origins and epidemiology of HIV-2, the natural history of infection, the main virological tools for monitoring the infection course, and the main mechanisms explaining the attenuated infection of HIV-2. We also indicate the points remaining to be explored. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
36. Cell death in individual freshwater phytoplankton species: relationships with population dynamics and environmental factors.
- Author
-
Kozik, Christine, Young, Erica B., Sandgren, Craig D., and Berges, John A.
- Subjects
CELL death ,POPULATION dynamics ,PHYTOPLANKTON ,FRESHWATER phytoplankton ,PHYTOPLANKTON populations ,MICROCYSTIS aeruginosa ,STAINS & staining (Microscopy) - Abstract
Understanding and predicting changes in phytoplankton populations requires knowledge of losses due not only to sedimentation and grazing, but also to intrinsic processes (here, collectively termed 'cell death'). Cell death is poorly understood, especially in freshwater phytoplankton, but experiments in culture often suggest involvement of abiotic factors (e.g. temperature, light, nutrients). The occurrence of cell death was examined in a simple, natural environment: a small, well-mixed, temperate, urban pond during a period of phytoplankton growth, from mid-July to mid-November. Abundances of 18 phytoplankton taxa were measured weekly and fluorescence microscopy and staining was used to detect dead cells (using SYTOX which measures loss of membrane integrity) and cells undergoing cell death (using Annexin-V, which measures lipid inversions of membranes, an early signal of cell death). Dead and dying cells occurred in most phytoplankton taxa, but incidence and timing varied considerably, e.g. species like the chlorophyte Ankistrodesmus spiralis showed 20–30% of cells staining with SYTOX and Annexin in late autumn when the population was decreasing, while the dinoflagellate Peridinium sp. showed staining of up to 50% of cells with STYOX throughout the period, and the cyanobacterium Microcystis aeruginosa occasionally showed staining of 100% of cells with SYTOX. Overall, there was some association between cell death staining and growth phase with 10–15% of the total community showing SYTOX and Annexin staining in late autumn, when most populations were declining. Cell death could not be correlated with thresholds or rapid changes in abiotic conditions (e.g. temperature, irradiance) or with indicators of nutrient limitation (e.g. N:P ratios). While abiotic factors have been clearly implicated in cell death within unialgal culture experiments, in natural freshwater ecosystems interactions between biotic factors, such as pathogens or allelopathy, may play greater roles in losses related to cell death and be distinct for different taxa. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
37. A purely quantitative form of partial recessive IFN-γR2 deficiency caused by mutations of the initiation or second codon.
- Author
-
Oleaga-Quintas, Carmen, Deswarte, Caroline, Moncada-Vélez, Marcela, Metin, Ayse, Rao, Indumathi Krishna, Kanık-Yüksek, Saliha, Nieto-Patlán, Alejandro, Guérin, Antoine, Gülhan, Belgin, and Murthy, Savita
- Published
- 2018
- Full Text
- View/download PDF
38. Biofilm formation and virulence factor analysis of Staphylococcus aureus isolates collected from ovine mastitis.
- Author
-
Azara, E., Longheu, C., Sanna, G., and Tola, S.
- Subjects
STAPHYLOCOCCUS aureus ,MASTITIS ,AUTOVACCINES ,HEMOLYSIS & hemolysins ,ENTEROTOXINS - Abstract
Aims To perform a phenotypic and genotypic characterization of 258 Staphylococcus aureus isolates from clinical ovine mastitis and used for the preparation of inactivated autogenous vaccines. Methods and Results The potential for biofilm production was determined by phenotypic test of Congo Red Agar ( CRA) and by PCR for the detection of icaA/D genes. Isolates were also screened by PCR for the presence of enterotoxins ( sea, seb, sec, sed and see), toxic shock syndrome toxin ( tsst), leukotoxins ( lukD-E, lukM and luk PV83), haemolysins ( hly-β and hly-γ), autolysin ( atlA) genes and encoding microbial surface components recognizing adhesive matrix molecules ( MSCRAMMs: clfA, clfB, fnbA, fnbB, bbp, cna, eno, fib, epbs, sdrC, sdrD and SdrE). None of the 258 isolates showed biofilm-forming ability on CRA and harboured icaA/D genes. The most frequent pyrogenic toxin superantigen genes amplified were sec plus tsst-1, which were found strictly in combination with 71·3% of the Staph. aureus isolates tested. None of the isolates harboured the genes encoding sea and see. Of the 258 isolates tested, 159 (61·6%) possessed all lukD-E/lukM/ luk PV83 genes, 123 (47·7%) harboured both hly-β/ hly-γ genes, whereas almost all (97·3%) were PCR positive for atlA gene. With respect to adhesion determinants, 179 (69·4%) isolates presented simultaneously four genes ( fnbA, fib, clfA and clfB) for fibronectin- and fibrinogen-binding proteins. Conclusions In this search, several putative virulence determinants have been identified in ovine Staph. aureus isolates collected in Sardinia. Significance and Impact of the Study Some of the putative virulence determinants could be considered as components of a vaccine because of their role in ovine mastitis pathogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
39. The emetic activity of staphylococcal enterotoxins, SEK, SEL, SEM, SEN and SEO in a small emetic animal model, the house musk shrew.
- Author
-
Ono, Hisaya K., Hirose, Shouhei, Naito, Ikunori, Sato'o, Yusuke, Asano, Krisana, Hu, Dong‐Liang, Omoe, Katsuhiko, and Nakane, Akio
- Subjects
STAPHYLOCOCCAL diseases ,STAPHYLOCOCCUS aureus ,EMETICS ,FOOD poisoning ,ANIMAL models in research ,SUNCUS murinus - Abstract
ABSTRACT Staphylococcal enterotoxins (SEs) produced by Staphylococcus aureus are the most recognizable causative agents of emetic food poisoning in humans. New types of SEs and SE-like (SEl) toxins have been reported. Several epidemiological investigations have shown that the SEs and SEl genes, particularly, SEK, SEL, SEM, SEN and SEO genes, are frequently detected in strains isolated from patients with food poisoning. The purpose of the present study was to evaluate the emetic activity of recently identified SEs using a small emetic animal model, the house musk shrew. The emetic activity of these SEs in house musk shrews was evaluated by intraperitoneal administration and emetic responses, including the number of shrews that vomited, emetic frequency and latency of vomiting were documented. It was found that SEs induce emetic responses in these animals. This is the first time to demonstrate that SEK, SEL, SEM, SEN and SEO possess emetic activity in the house musk shrew. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
40. Gene therapy for monogenic disorders of the bone marrow.
- Author
-
Ghosh, Sujal, Thrasher, Adrian J., and Gaspar, H. Bobby
- Subjects
GENE therapy ,IMMUNODEFICIENCY ,BONE marrow diseases ,HEMOGLOBINOPATHY ,METABOLIC disorders - Abstract
Ex-vivo gene transfer of autologous haematopoietic stem cells in patients with monogenic diseases of the bone marrow has emerged as a new therapeutic approach, mainly in patients lacking a suitable donor for transplant. The encouraging results of initial clinical trials of gene therapy for primary immunodeficiencies were tempered by the occurrence of genotoxicity in a number of patients. Over the last decade, safer viral vectors have been developed to overcome the risk of insertional mutagenesis and have led to impressive clinical outcomes with considerably improved safety. We review the efforts in specific immunodeficiencies including adenosine deaminase deficiency, X-linked severe combined immunodeficiency, chronic granulomatous disease and Wiskott Aldrich syndrome. Major recent progress has also been made in haemoglobinopathies, such as beta-thalassaemia, sickle cell disease and Fanconi anaemia, and also specific lysosomal storage diseases, which, although not strictly bone marrow specific conditions, have been effectively treated by bone marrow-based treatment. The success of these recent studies and the advent of new technologies, such as gene editing, suggest that gene therapy could become a more generally applied treatment modality for a number of haematopoietic disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
41. Raltegravir Inclusion Decreases CD4 T-Cells Intra-Cellular Viral Load and Increases CD4 and CD28 Positive T-Cells in Selected HIV Patients.
- Author
-
Kumar, Gaurav, Cottalorda-Dufayard, Jacqueline, Garraffo, Rodolphe, De Salvador-Guillouët, Francine, Cua, Eric, and Roger, Pierre-Marie
- Subjects
T cells ,CD28 antigen ,CD4 antigen ,HIV-positive persons ,RALTEGRAVIR ,VIRAL load - Abstract
Raltegravir (RLT) prevents the integration of HIV DNA in the nucleus, but published studies remain controversial, suggesting that it does not decrease proviral DNA. However, there are only a few studies focused on virus-targeted cells. We aimed our study on the impact of RLT inclusion on total intra-cellular viral DNA (TID) in cellular subsets and immune effects in patients with newly acquired undetectable plasmatic viral load (UVL). Six patients having UVL using an antiretroviral combination for 6 months and CD4 T-cells > 350/mL and <500/mL were selected to receive RLT for 3 months from M0 to M3. Patients had 7 sequential viro-immunological determinations from M-1 to M5. Immune phenotypes were determined by flow cytometry and TID quantification was performed using PCR assay on purified cells. TID (median values) at the initiation of RLT in CD4 T-cells was 117 copies/millions of cells, decreased to 27.5 on M3, and remained thereafter permanently under the cut-off (<10 copies/millions of cells) in 4 out of 6 patients. This was associated with an increase of CD4 and CD4 + CD28+ T-cells and a decrease of HLA-DR expression and apoptosis of CD4 T-cells. RLT inclusion led to decreases in the viral load along with positive immune reconstitution, mainly for CD4 T-cells in HIV patients. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
42. Interaction between the Hepatitis B Virus and Cellular FLIP Variants in Viral Replication and the Innate Immune System.
- Author
-
Lee, Ah Ram, Park, Yong Kwang, Dezhbord, Mehrangiz, and Kim, Kyun-Hwan
- Subjects
HEPATITIS B virus ,VIRAL replication ,IMMUNE system ,VIRAL hepatitis ,VIRAL proteins ,HEPATOCELLULAR carcinoma - Abstract
During viral evolution and adaptation, many viruses have utilized host cellular factors and machinery as their partners. HBx, as a multifunctional viral protein encoded by the hepatitis B virus (HBV), promotes HBV replication and greatly contributes to the development of HBV-associated hepatocellular carcinoma (HCC). HBx interacts with several host factors in order to regulate HBV replication and evolve carcinogenesis. The cellular FADD-like IL-1β-converting enzyme (FLICE)-like inhibitory protein (c-FLIP) is a major factor that functions in a variety of cellular pathways and specifically in apoptosis. It has been shown that the interaction between HBx and c-FLIP determines HBV fate. In this review, we provide a comprehensive and detailed overview of the interplay between c-FLIP and HBV in various environmental circumstances. We describe strategies adapted by HBV to establish its chronic infection. We also summarize the conventional roles of c-FLIP and highlight the functional outcome of the interaction between c-FLIP and HBV or other viruses in viral replication and the innate immune system. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
43. Towards a Four-Component GMMA-Based Vaccine against Shigella.
- Author
-
Micoli, Francesca, Nakakana, Usman N., and Berlanda Scorza, Francesco
- Subjects
SHIGELLOSIS ,SHIGELLA ,DRUG resistance in microorganisms ,BACTERIAL cell walls ,MIDDLE-income countries ,EXTRACELLULAR vesicles - Abstract
Shigellosis remains a major public health problem around the world; it is one of the leading causes of diarrhoeal disease in low- and middle-income countries, particularly in young children. The increasing reports of Shigella cases associated with anti-microbial resistance are an additional element of concern. Currently, there are no licensed vaccines widely available against Shigella, but several vaccine candidates are in development. It has been demonstrated that the incidence of disease decreases following a prior Shigella infection and that serum and mucosal antibody responses are predominantly directed against the serotype-specific Shigella O-antigen portion of lipopolysaccharide membrane molecules. Many Shigella vaccine candidates are indeed O-antigen-based. Here we present the journey towards the development of a potential low-cost four-component Shigella vaccine, eliciting broad protection against the most prevalent Shigella serotypes, that makes use of the GMMA (Generalized Modules for Membrane Antigens) technology, a novel platform based on bacterial outer membranes for delivery of the O-antigen to the immune system. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
44. Immune Dysregulation Is Associated with Neurodevelopment and Neurocognitive Performance in HIV Pediatric Populations—A Scoping Review.
- Author
-
Williams, Monray E., Janse Van Rensburg, Anicia, Loots, Du Toit, Naudé, Petrus J. W., and Mason, Shayne
- Subjects
HIV-positive children ,CHILD patients ,NEURAL development ,BIOMARKERS ,SCIENCE databases ,HIV - Abstract
HIV-1 is known for its complex interaction with the dysregulated immune system and is responsible for the development of neurocognitive deficits and neurodevelopmental delays in pediatric HIV populations. Considering that HIV-1-induced immune dysregulation and its association with neurodevelopmental and neurocognitive impairments in pediatric populations are not well understood, we conducted a scoping review on this topic. The study aimed to systematically review the association of blood and cerebrospinal fluid (CSF) immune markers with neurocognitive deficits and neurodevelopmental delays in pediatric HIV populations. PubMed, Scopus, and Web of Science databases were searched using a search protocol designed specifically for this study. Studies were selected based on a set eligibility criterion. Titles, abstracts, and full texts were assessed by two independent reviewers. Data from the selected studies were extracted and analyzed by two independent reviewers. Seven studies were considered eligible for use in this context, which included four cross-sectional and three longitudinal studies. An average of 130 (±70.61) children living with HIV, 138 (±65.37) children exposed to HIV but uninfected and 90 (±86.66) HIV-negative participants were included across the seven studies. Results indicate that blood and CSF immune markers are associated with neurocognitive development/performance in pediatric HIV populations. Only seven studies met the inclusion criteria, therefore, these limited the number of significant conclusions which could have been made by using such an approach. All considered, the evidence suggests that immune dysregulation, as in the case of adult HIV populations, also has a significant association with neurocognitive performance in pediatric HIV populations. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
45. The Contribution of Human Herpes Viruses to γδ T Cell Mobilisation in Co-Infections.
- Author
-
Martini, Fanny and Champagne, Eric
- Subjects
T cells ,PARASITIC diseases ,BACTERIAL diseases ,MIXED infections ,VIRUSES ,HUMAN beings - Abstract
γδ T cells are activated in viral, bacterial and parasitic infections. Among viruses that promote γδ T cell mobilisation in humans, herpes viruses (HHVs) occupy a particular place since they infect the majority of the human population and persist indefinitely in the organism in a latent state. Thus, other infections should, in most instances, be considered co-infections, and the reactivation of HHV is a serious confounding factor in attributing γδ T cell alterations to a particular pathogen in human diseases. We review here the literature data on γδ T cell mobilisation in HHV infections and co-infections, and discuss the possible contribution of HHVs to γδ alterations observed in various infectious settings. As multiple infections seemingly mobilise overlapping γδ subsets, we also address the concept of possible cross-protection. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
46. Antibody and Protein Profiles in Glaucoma: Screening of Biomarkers and Identification of Signaling Pathways.
- Author
-
Auler, Nadine, Tonner, Henrik, Pfeiffer, Norbert, and Grus, Franz H.
- Subjects
OPEN-angle glaucoma ,CELLULAR signal transduction ,GLAUCOMA ,VISION disorders ,THERAPEUTICS - Abstract
Simple Summary: Glaucoma is a chronic eye disease that is one of the leading causes of blindness worldwide. Currently, the only therapeutic option is to lower intraocular pressure. The onset of the disease is often delayed because patients do not notice visual impairment until very late, which is why glaucoma is also known as "the silent thief of sight". Therefore, early detection and definition of specific markers, the so-called biomarkers, are immensely important. For the methodical implementation, high-throughput methods and omic-based methods came more and more into focus. Thus, interesting targets for possible biomarkers were already suggested by clinical research and basic research, respectively. This review article aims to join the findings of the two disciplines by collecting overlaps as well as differences in various clinical studies and to shed light on promising candidates concerning findings from basic research, facilitating conclusions on possible therapy options. Glaucoma represents a group of chronic neurodegenerative diseases, constituting the second leading cause of blindness worldwide. To date, chronically elevated intraocular pressure has been identified as the main risk factor and the only treatable symptom. However, there is increasing evidence in the recent literature that IOP-independent molecular mechanisms also play an important role in the progression of the disease. In recent years, it has become increasingly clear that glaucoma has an autoimmune component. The main focus nowadays is elucidating glaucoma pathogenesis, finding early diagnostic options and new therapeutic approaches. This review article summarizes the impact of different antibodies and proteins associated with glaucoma that can be detected for example by microarray and mass spectrometric analyzes, which (i) provide information about expression profiles and associated molecular signaling pathways, (ii) can possibly be used as a diagnostic tool in future and, (iii) can identify possible targets for therapeutic approaches. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
47. Prompt Graft Cooling Enhances Cardioprotection during Heart Transplantation Procedures through the Regulation of Mitophagy.
- Author
-
Wu, Zhichao, Liang, Jialiang, Huang, Wei, Jiang, Lin, Paul, Christian, Lin, Bonnie, Zheng, Junmeng, and Wang, Yigang
- Subjects
HEART ,HEART transplantation ,AUTOPHAGY ,OPERATIVE surgery ,SYSTOLIC blood pressure ,LABORATORY mice ,COOLING - Abstract
A complete and prompt cardiac arrest using a cold cardioplegic solution is routinely used in heart transplantation to protect the graft function. However, warm ischemic time is still inevitable during the procedure to isolate donor hearts in the clinical setting. Our knowledge of the mechanism changes prevented by cold storage, and how warm ischemia damages donor hearts, is extremely poor. The potential consequences of this inevitable warm ischemic time to grafts, and the underlying potential protective mechanism of prompt graft cooling, have been studied in order to explore an advanced graft protection strategy. To this end, a surgical procedure, including 10–15 min warm ischemic time during procurement, was performed in mouse models to mimic the clinical situation (Group I), and compared to a group of mice that had the procurement performed with prompt cooling procedures (Group II). The myocardial morphologic changes (including ultrastructure) were then assessed by electron and optical microscopy after 6 h of cold preservation. Furthermore, syngeneic heart transplantation was performed after 6 h of cold preservation to measure the graft heart function. An electron microscopy showed extensive damage, including hypercontracted myofibers with contraction bands, and damaged mitochondria that released mitochondrial contents in Group I mice, while similar patterns of damage were not observed in the mice from Group II. The results from both the electron microscopy and immunoblotting verified that cardiac mitophagy (protective mitochondrial autophagy) was present in the mice from Group II, but was absent in the mice from Group I. Moreover, the mice from Group II demonstrated faster rebeating times and higher beating scores, as compared to the mice from Group I. The pressure catheter system results indicated that the graft heart function was significantly more improved in the mice from Group II than in those from Group I, as demonstrated by the left ventricle systolic pressure (31.96 ± 6.54 vs. 26.12 ± 8.87 mmHg), the +dp/dt (815.6 ± 215.4 vs. 693.9 ± 153.8 mmHg/s), and the -dp/dt: (492.4 ± 92.98 vs. 418.5 ± 118.9 mmHg/s). In conclusion, the warm ischemic time during the procedure impaired the graft function and destroyed the activation of mitophagy. Thus, appropriate mitophagy activation has emerged as a promising therapeutic target that may be essential for graft protection and functional improvement during heart transplantation. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
48. Human Immunodeficiency Virus Type 2: The Neglected Threat.
- Author
-
Ceccarelli, Giancarlo, Giovanetti, Marta, Sagnelli, Caterina, Ciccozzi, Alessandra, d'Ettorre, Gabriella, Angeletti, Silvia, Borsetti, Alessandra, and Ciccozzi, Massimo
- Subjects
HIV infections ,HIV ,NON-nucleoside reverse transcriptase inhibitors ,SYMPTOMS ,MEDICAL personnel ,TREATMENT failure - Abstract
West Africa has the highest prevalence of human immunodeficiency virus (HIV)-2 infection in the world, but a high number of cases has been recognized in Europe, India, and the United States. The virus is less transmissible than HIV-1, with sexual contacts being the most frequent route of acquisition. In the absence of specific antiretroviral therapy, most HIV-2 carriers will develop AIDS. Although, it requires more time than HIV-1 infection, CD4+ T cell decline occurs more slowly in HIV-2 than in HIV-1 patients. HIV-2 is resistant to non-nucleoside reverse transcriptase inhibitors (NNRTIs) and some protease inhibitors. Misdiagnosis of HIV-2 in patients mistakenly considered HIV-1-positive or in those with dual infections can cause treatment failures with undetectable HIV-1 RNA. In this era of global integration, clinicians must be aware of when to consider the diagnosis of HIV-2 infection and how to test for this virus. Although there is debate regarding when therapy should be initiated and which regimen should be chosen, recent trials have provided important information on treatment options for HIV-2 infection. In this review, we focus mainly on data available and on the insight they offer about molecular epidemiology, clinical presentation, antiretroviral therapy, and diagnostic tests of HIV-2 infection. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
49. Activation of Peripheral Blood Mononuclear Cells and Leptin Secretion: New Potential Role of Interleukin-2 and High Mobility Group Box (HMGB)1.
- Author
-
Coppola, Andrea, Capuani, Barbara, Pacifici, Francesca, Pastore, Donatella, Arriga, Roberto, Bellia, Alfonso, Andreadi, Aikaterini, Di Daniele, Nicola, Lauro, Renato, Della-Morte, David, Sconocchia, Giuseppe, and Lauro, Davide
- Subjects
MONONUCLEAR leukocytes ,LEPTIN ,SECRETION ,INTERLEUKIN-2 ,TYPE 2 diabetes - Abstract
Activation of innate immunity and low-grade inflammation contributes to hyperglycemia and an onset of Type 2 Diabetes Mellitus (T2DM). Interleukin-2 (IL-2), leptin, High Mobility Group Box-1 (HMGB-1), and increased glucose concentrations are mediators of these processes also by modulating peripheral blood mononuclear cells (PBMCs) response. The aim of this study was to investigate if HMGB-1 and IL-2 turn on PBMCs and their leptin secretion. In isolated human PBMCs and their subpopulations from healthy individuals and naïve T2DM patients, leptin release, pro-inflammatory response and Toll-like Receptors (TLRs) activation was measured. After treatment with IL-2 and HMGB1, NK (Natural Killer) have the highest amount of leptin secretion, whilst NK-T have the maximal release in basal conditions. TLR4 (TAK242) and/or TLR2 (TLR2-IgA) inhibitors decreased leptin secretion after IL-2 and HMGB1 treatment. A further non-significant increase in leptin secretion was reported in PBMCs of naive T2DM patients in response to IL-2 and HMGB-1 stimulation. Finally, hyperglycemia or hyperinsulinemia might stimulate leptin secretion from PBMCs. The amount of leptin released from PBMCs after the different treatments was enough to stimulate the secretion of IL-1β from monocytes. Targeting leptin sera levels and secretion from PBMCs could represent a new therapeutic strategy to counteract metabolic diseases such as T2DM. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
50. Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders?
- Author
-
Borrajo López, Ana, Penedo, Maria Aránzazu, Rivera-Baltanas, Tania, Pérez-Rodríguez, Daniel, Alonso-Crespo, David, Fernández-Pereira, Carlos, Olivares, José Manuel, and Agís-Balboa, Roberto Carlos
- Subjects
NEUROBEHAVIORAL disorders ,MICROGLIA ,HIV ,CENTRAL nervous system ,DRUG therapy - Abstract
The current use of combined antiretroviral therapy (cART) is leading to a significant decrease in deaths and comorbidities associated with human immunodeficiency virus type 1 (HIV-1) infection. Nonetheless, none of these therapies can extinguish the virus from the long-lived cellular reservoir, including microglia, thereby representing an important obstacle to curing HIV. Microglia are the foremost cells infected by HIV-1 in the central nervous system (CNS) and are believed to be involved in the development of HIV-1-associated neurocognitive disorder (HAND). At present, the pathological mechanisms contributing to HAND remain unclear, but evidence suggests that removing these infected cells from the brain, as well as obtaining a better understanding of the specific molecular mechanisms of HIV-1 latency in these cells, should help in the design of new strategies to prevent HAND and achieve a cure for these diseases. The goal of this review was to study the current state of knowledge of the neuropathology and research models of HAND containing virus susceptible target cells (microglial cells) and potential pharmacological treatment approaches under investigation. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.